Combined immunosuppressive therapy of active lupus nephritis – retrospective analysis of its practice and efficacy in a multicentre cohort (LUPUS 2026) - Feb 17, 2026 - Abstract #PO:10:263; 13; Pres time: Mar 6, 2026; 07:30 AM - 07:30 PM; Location: Poster Area; "ISU therapies were mycophenolate mofetil in 53, iv. cyclophosphamide in 8, rituximab in 25, belimumab in 16, obinutuzumab in 2, voclosporin in 21, tacrolimus in 6, cyclosporin-A in 4 and azathioprine in 3 patients...Conclusions Combined ISU therapy is increasingly used as a favoured option for the treatment of LN in our centres. Renal response rates are high, and the combined therapy is suitable for long-term use with high patient retention rates."
Retrospective data • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis
|
|
Peter Kovacs; Nikolett Farmasi; Szabina Czirok; Agnes Horvath; Rita Bakai; Gabor Kumanovics; Gabriella Szucs; Zoltan Szekanecz; Emese Kiss; Gyorgy Nagy; Laszlo Kovacs; Tunde Tarr
|